Product Information
FEMARA 2.5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $27.1160 per EA under NDC 00078024915. Its NADAC has been published 353 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the letrozole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078024915
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/7/2026
Active Ingredients
LETROZOLEApproval Type
New Drug (NDA)
FDA Application
NDA020726On Market Since
7/31/1997
Pharmacological Classes
Price Statistics
The NADAC for FEMARA 2.5 MG TABLET has been published 353 times since Nov 28, 2013, and over the history we have for it it has risen 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.1160 per EA |
|---|---|
| All-time high | $27.1160 (Jun 24, 2026) |
| All-time low | $18.1938 (Nov 28, 2013) |
| 52-week high | $27.1160 |
| 52-week low | $26.2823 |
| Median price | $22.6235 |
| Average price | $22.8953 |
| Largest weekly change | +13.3% (Sep 18, 2024) |
| Weeks tracked | 353 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEMARA 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEMARA 2.5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $27.1160 per EA (NDC 00078024915), effective Jun 24, 2026.
How has the price of FEMARA 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEMARA 2.5 MG TABLET has risen 49.0%. It has been tracked across 353 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FEMARA 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for FEMARA 2.5 MG TABLET has ranged from a low of $18.1938 (Nov 28, 2013) to a high of $27.1160 (Jun 24, 2026), with a median of $22.6235 per EA.
Are there cheaper alternatives to FEMARA 2.5 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LETROZOLE 2.5 MG TABLET, is $0.1535 per EA — about 99% below FEMARA 2.5 MG TABLET.
Who manufactures FEMARA 2.5 MG TABLET?
FEMARA 2.5 MG TABLET (NDC 00078024915) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.